Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FELPX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,488
Award facts
- Contract value 100% obligated
- $18,488.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 7, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing comprehensive ranges of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally.
This delivery order falls under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy through which the DLA established multiple regional prime vendor contractors. DMS Pharmaceutical Group's IDC under this program, designated as contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with completion through December 31, 2036. The company's product portfolio encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables, including oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals. No subcontractor relationships have been identified in the award documentation, with DMS Pharmaceutical Group serving directly as the prime contractor for all identified federal contract awards.
Quick answers
Who was awarded contract SPE2DU26FELPX?
SPE2DU26FELPX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DU26FELPX worth?
The government has obligated $18,488 on SPE2DU26FELPX.
Is contract SPE2DU26FELPX an order under another contract?
Yes. SPE2DU26FELPX is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELPX competed?
The extent of competition for SPE2DU26FELPX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award